Approval of migraine medications, including Emgality and Aimovigis, are subject to Alberta Blue Cross Special Authorization criteria. Patients must request that their specialist (i.e. neurologist) complete the Special Authorization form and submit it directly to Alberta Blue Cross for review and approval. ASEBP doesn’t need to review or receive copies of Special Authorization forms. See the Drug Inquiry Tool on My ASEBP for eligibility details on specific drugs.
Enhanced Plan: 100%
Join us November 9, 2023, from 8:30 a.m. to 2 p.m. (MST), for a virtual Retirement Seminar (hosted by ASEBP). Guest speakers will share valuable information about pensions (LAPP and ATRF), nurturing your mental health and wellbeing during retirement, retirement financial planning, Alberta's Coverage for Seniors benefits, optional trip interruption and cancellation insurance, and ASEBP's MyRetiree Plan: An Overview.